These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37495706)

  • 1. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
    Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
    Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
    J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P; Shi YH; Li JY; Zhang CZ
    World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Radiomics features of Peritumoral Vasogenic Edema extracted from fluid-attenuated inversion recovery images in glioblastoma and isolated brain metastasis, using T1-dynamic contrast-enhanced Perfusion analysis.
    Parvaze PS; Bhattacharjee R; Verma YK; Singh RK; Yadav V; Singh A; Khanna G; Ahlawat S; Trivedi R; Patir R; Vaishya S; Shah TJ; Gupta RK
    NMR Biomed; 2023 May; 36(5):e4884. PubMed ID: 36453877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.
    Krishnan AP; Karunamuni R; Leyden KM; Seibert TM; Delfanti RL; Kuperman JM; Bartsch H; Elbe P; Srikant A; Dale AM; Kesari S; Piccioni DE; Hattangadi-Gluth JA; Farid N; McDonald CR; White NS
    AJNR Am J Neuroradiol; 2017 May; 38(5):882-889. PubMed ID: 28279985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype?
    Demerath T; Simon-Gabriel CP; Kellner E; Schwarzwald R; Lange T; Heiland DH; Reinacher P; Staszewski O; Mast H; Kiselev VG; Egger K; Urbach H; Weyerbrock A; Mader I
    Neuroradiol J; 2017 Feb; 30(1):36-47. PubMed ID: 27864578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
    Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
    AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
    Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
    Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
    Harris RJ; Cloughesy TF; Pope WB; Godinez S; Natsuaki Y; Nghiemphu PL; Meyer H; Paul D; Behbahanian Y; Lai A; Ellingson BM
    J Neurooncol; 2013 Apr; 112(2):257-66. PubMed ID: 23344788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
    Boxerman JL; Zhang Z; Safriel Y; Rogg JM; Wolf RL; Mohan S; Marques H; Sorensen AG; Gilbert MR; Barboriak DP
    Neuro Oncol; 2018 Sep; 20(10):1400-1410. PubMed ID: 29590461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
    John F; Bosnyák E; Robinette NL; Amit-Yousif AJ; Barger GR; Shah KD; Michelhaugh SK; Klinger NV; Mittal S; Juhász C
    Neuro Oncol; 2019 Feb; 21(2):264-273. PubMed ID: 30346623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.
    Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
    Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
    Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
    Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
    Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
    Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Neural Network Approach to Identify the Peritumoral Invasive Areas in Glioblastoma Patients by Using MR Radiomics.
    Yan JL; Li C; van der Hoorn A; Boonzaier NR; Matys T; Price SJ
    Sci Rep; 2020 Jun; 10(1):9748. PubMed ID: 32546790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging.
    Abecassis IJ; Cordy B; Durfy S; Andre JB; Levitt MR; Ellenbogen RG; Silbergeld DL; Ko AL
    J Clin Neurosci; 2020 Jun; 76():46-52. PubMed ID: 32312627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulcal hyperintensity on fluid-attenuated inversion recovery mr images in patients without apparent cerebrospinal fluid abnormality.
    Taoka T; Yuh WT; White ML; Quets JP; Maley JE; Ueda T
    AJR Am J Roentgenol; 2001 Feb; 176(2):519-24. PubMed ID: 11159107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.